- Press releases
- Country: United States
BioMimetix Announces Publication of Phase I/II Clinical Trial Evaluating BMX-001 in Patients With Locally Advanced Head and Neck Cancer
Results demonstrate a favorable safety profile and reduction of treatment-related toxicities during chemoradiation therapy ENGLEWOOD, Colo., Nov. 19, 2026 /PRNewswire/ -- BioMimetix JV, LLC today announced the publication of results from a NCI funded multicenter Phase I/II clinical trial...